A precision medicine trial of bupropion and sertraline for major depressive disorder using a biomarker-guided sequential multiple-assignment design.

Zhukovsky P, Kuhn M, Borchers LR, Ren B, Woronko SE, Li M, Lam CST, Zhang EM, Ressler KJ, Brennan BP, Vitaliano G, Pizzagalli DA

Open source

DOI: 10.1038/s44220-026-00671-z
Published: 2026
Container: Nature. Mental health
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s44220-026-00671-z,
  title = {A precision medicine trial of bupropion and sertraline for major depressive disorder using a biomarker-guided sequential multiple-assignment design.},
  author = {Zhukovsky P and Kuhn M and Borchers LR and Ren B and Woronko SE and Li M and Lam CST and Zhang EM and Ressler KJ and Brennan BP and Vitaliano G and Pizzagalli DA},
  year = {2026},
  journal = {Nature. Mental health},
  doi = {10.1038/s44220-026-00671-z},
  url = {https://doi.org/10.1038/s44220-026-00671-z}
}

RIS

TY  - JOUR
TI  - A precision medicine trial of bupropion and sertraline for major depressive disorder using a biomarker-guided sequential multiple-assignment design.
AU  - Zhukovsky P
AU  - Kuhn M
AU  - Borchers LR
AU  - Ren B
AU  - Woronko SE
AU  - Li M
AU  - Lam CST
AU  - Zhang EM
AU  - Ressler KJ
AU  - Brennan BP
AU  - Vitaliano G
AU  - Pizzagalli DA
PY  - 2026
JO  - Nature. Mental health
DO  - 10.1038/s44220-026-00671-z
UR  - https://doi.org/10.1038/s44220-026-00671-z
ER  -

APA

P, Z., M, K., LR, B., B, R., SE, W., M, L., CST, L., EM, Z., KJ, R., BP, B., G, V., & DA, P. (2026). A precision medicine trial of bupropion and sertraline for major depressive disorder using a biomarker-guided sequential multiple-assignment design.. Nature. Mental health. https://doi.org/10.1038/s44220-026-00671-z

Source records

pubmed · retrieved 2026-09-26T23:16:38.156Z